Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1361 - 1368 of 11439 results
IP Strategies for 2023 Informed by Top 2022 IP Issues
January 5, 2023| Blog| Viewpoint
Data Center Real Estate 2023: Experts Predict Development Slowdown, More Power Problems
January 5, 2023| News
Congress Expands Protections for Pregnant and Nursing Employees
January 4, 2023| Blog| Viewpoint
FTC And $391-Million State AG Case Put Location Data Enforcement On The Map
January 4, 2023| News
New Law Hikes HSR Merger Filing Fees for Large Deals and Imposes Foreign Subsidy Disclosure Requirement
January 3, 2023| Alert| Viewpoint
What’s New in 5G - January 2023
January 3, 2023| Blog| Viewpoint
Mintz Recruits Milbank Partner To Build New Miami Office
January 3, 2023| News
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.